Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine
- 1 March 2001
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 49 (3) , 665-671
- https://doi.org/10.1016/s0360-3016(00)01388-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Current chemotherapeutic possibilities in pancreaticobiliary cancerAnnals of Oncology, 1999
- Chemoradiation for pancreatic and biliary cancer: Current status of RTOG studiesAnnals of Oncology, 1999
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Gemcitabine in Solid Tumors – Present Status and Further DevelopmentOncology Research and Treatment, 1997
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Pancreatic CarcinomaNew England Journal of Medicine, 1992
- Saturation of 2?, 2?-difluorodeoxycytidine 5?-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabineCancer Chemotherapy and Pharmacology, 1991
- Patterns of failure after curative resection of pancreatic carcinomaCancer, 1990
- Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancerCancer, 1987
- Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973—Analysis of surgical failure and implications for radiation therapyCancer, 1976